| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 445.09B | 441.88B | 407.01B | 359.68B | 331.48B |
| Gross Profit | 215.41B | 187.63B | 170.46B | 142.62B | 121.87B |
| EBITDA | 94.89B | 99.08B | 90.82B | 73.96B | 61.35B |
| Net Income | 28.28B | 41.42B | 29.91B | 14.24B | 4.32B |
Balance Sheet | |||||
| Total Assets | 1.14T | 1.16T | 1.11T | 1.12T | 1.19T |
| Cash, Cash Equivalents and Short-Term Investments | 36.10B | 54.98B | 71.34B | 39.87B | 93.28B |
| Total Debt | 336.68B | 363.58B | 364.40B | 413.95B | 502.11B |
| Total Liabilities | 713.54B | 740.91B | 720.49B | 749.54B | 830.78B |
| Stockholders Equity | 415.59B | 409.65B | 381.90B | 359.38B | 350.37B |
Cash Flow | |||||
| Free Cash Flow | 52.84B | 71.40B | 83.66B | 56.84B | 44.05B |
| Operating Cash Flow | 66.99B | 85.81B | 90.69B | 65.48B | 49.87B |
| Investing Cash Flow | -15.15B | -28.31B | 13.43B | -13.37B | -5.29B |
| Financing Cash Flow | -70.78B | -74.00B | -72.75B | -105.69B | -80.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥1.07T | 9.13 | 9.37% | 2.59% | -1.40% | -14.78% | |
69 Neutral | ¥598.36B | 44.20 | 7.58% | 2.58% | 0.73% | -29.55% | |
66 Neutral | ¥284.04B | 2.68 | 4.97% | 2.01% | 0.87% | -38.26% | |
65 Neutral | ¥999.40B | 14.50 | 9.25% | 1.48% | -3.73% | 8.13% | |
64 Neutral | ¥1.99T | 39.08 | 17.34% | 0.72% | 16.20% | 16.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥563.21B | -3.91 | 9.06% | 1.84% | -1.23% | -121.69% |